Human polyvalent immunoglobulin: new indication. Multifocal motor neuropathy: slightly more muscle strength. Improvement in muscle strength, but frequent hypersensitivity reactions.
D017277:Drug Approval; D005602:France; D006801:Humans; D007070:Immunoglobulin A / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D053580:Muscle Strength / Q000187:drug effects*; D011115:Polyneuropathies / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D007070:Immunoglobulin A; D016756:Immunoglobulins, Intravenous